Publisher： Bentham Science Publishers
E-ISSN： 1875-5704|2|4|363-368
ISSN： 1567-2018
Source： Current Drug Delivery, Vol.2, Iss.4, 2005-10, pp. : 363-368
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Active targeting of angiogenic vasculature represents a promising therapeutic strategy to fight a variety of diseases. In particular, attention has been focused on inhibition of tumor growth. In this review, the recent progress in targeting liposomes to angiogenic endothelial cells is discussed.
Related content
By Hare Jennifer I. Moase Elaine H. Allen Theresa M.
Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. :
Access to resources
Recommend
Targeting Tumor Vasculature: Reality or a Dream?
Journal of Drug Targeting, Vol. 10, Iss. 7, 2002-01 ,pp. :
Clinical Use of Therapies Targeting Tumor Vasculature and Stroma
Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-09 ,pp. :
Evaluation of Drug Targeting Strategies and Liposomal Trafficking.
Current Pharmaceutical Design, Vol. 6, Iss. 16, 2000-11 ,pp. :
PEGylated Elastic Liposomal Formulation for Lymphatic Targeting of Zidovudine
Current Drug Delivery, Vol. 5, Iss. 4, 2008-10 ,pp. :